Happily for investors, Pfizer is generating enough cash flow to cover its dividend. In 2024, it paid $9.5 billion in ...

Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

You may know 175-year-old pharmaceutical company Pfizer (NYSE: PFE) best for its COVID-19 vaccine, but investors have long ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

UBS reduced its price target on Pfizer (NYSE:PFE) to $24 from $28, maintaining a Neutral rating as the firm highlights ...

Pfizer stock fell to the lowest closing price since 2012, putting its yield near 8%, after cautious comments from a UBS ...

Pfizer Inc. (NYSE:PFE) is one of the world’s biggest drug ... primarily driven by the VYNDAQEL family, PADCEV, Eliquis, and NURTEC, while also achieving expanded margins through cost management ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

If you’re in a group being offered the vaccine you will likely get a text reminder from the NHS. Pfizer's Comirnaty and Moderna's Spikevax vaccines are currently the 2 types of vaccines offered in the ...

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other blue chip stocks to ...